Friberg S. BCG in the treatment of superficial cancer of the bladder: a review. Med Oncol Tumor Pharmacother. 1993;10:31-36.S. Friberg, 1993, “BCG in the treatment of superficial cancer of the bladder: A review”, Med Oncol Tumor Pharmacother 10:31-36. ;31-36....
Bacillus Calmette–Guerin (BCG) intravesical instillation therapy is the most effective adjuvant therapy for bladder cancer after transurethral resection of bladder tumor. However, Bacillus Calmette–Guerin therapy is associated with a high risk o...
E16600 E16600- Interim results from a phase II study of tislelizumab combined with radiotherapy as bladder-preserving treatment for patients with high-risk non-muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacil...
BCG is used to treatbladder cancerthat is localized (has not spread to other parts of the body). BCG may also be used for purposes not listed in this medication guide. BCG side effects Get emergency medical help if you havesigns of an allergic reaction:hives; difficult breathing; swelling ...
The initial clinical stage and grade of bladder cancer remains the main determinant factors in survival, irrespective of the treatment. Intravesical chemotherapy has shown a decrease in short-term tumor recurrence rates, but has had no positive impact on disease progression or prolongation of survival...
Intravesical bacillus Calmette-Guerin (BCG) has been established as an effective treatment of superficial bladder cancer (Parker and Kommu, 2013). However, major side effects, including pneumonitis, sepsis, and even death, may occur in <5% of patients (Gonzalez et al., 2003). Here we present...
Findings In this cohort study of 6467 patients with non–muscle-invasive bladder cancer, treatment with intravesical BCG vaccine was associated with a reduced risk of ADRD in the presence of death as a competing risk. However, the risk differences varied with time. Meaning The findings of this...
-a treatment that controlssuperficial bladder cancer, particularlycarcinoma in situ. I was surprised tolearn that an ancient vaccine, originallydesigned to prevent tuberculosis (TB), isemployed for a completely unrelatedindication and is the current treatment ofchoice for bladder cancer. I thought that...
Urdaneta G,Solsona E, et al.Intravesical Chemotherapy and BCG for the Treatment of Bladder Cancer:Evidence and Opinion. European Urology . 2008Guillermo Urdaneta,Eduardo Solsona,Juan Palou.Intravesical Chemotherapy and BCG for the Treatment of Bladder Cancer: Evidence and Opinion ...
However, the incidence of recurrence and progression to invasive cancer is commonly observed. There are no established effective intravesical therapies available for patients, whose tumors recur following BCG treatment, representing an important unmet clinical need. In addition, there are very limited ...